galactose has been researched along with itraconazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM | 1 |
| Avila, N; Bacher, J; Candelario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, S; Sein, T; Walsh, TJ | 1 |
| Gugel, A; Laverdiere, M; Leisenring, W; Marr, KA | 1 |
| Abrahamsen, TG; Gaustad, P; Warris, A; Winn, RM | 1 |
| Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA | 1 |
| Afroz, S; Alam, MK; El-Ganiny, AM; Kaminskyj, SG; Liu, J; Sanders, DA | 1 |
| Cheong, JW; Cho, IS; Choi, YJ; Jang, JH; Jo, DY; Kang, HJ; Kim, BS; Kim, HG; Kim, HY; Kim, JS; Kim, JY; Kim, MK; Kim, SH; Kim, SJ; Kim, YS; Kwak, JY; Lee, DG; Lee, JH; Lee, SM; Min, YH; Mun, YC; Park, BB; Park, J; Ryoo, HM; Yang, DH | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Choi, HG; Choi, YK; Kim, JO; Kim, JW; Marasini, N; Poudel, BK; Yang, KY; Yong, CS | 1 |
| Goindi, S; Kumar, N | 1 |
| Heravi, G; Khazaeli, P; Moazeni, E; Mostafavi, M; Sharifi, I; Talebian, E | 1 |
2 trial(s) available for galactose and itraconazole
| Article | Year |
|---|---|
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Child; False Negative Reactions; Female; Fluconazole; Galactose; Humans; Immunoenzyme Techniques; Itraconazole; Male; Mannans; Middle Aged; Sensitivity and Specificity | 2005 |
Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea.
Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Coccidioidomycosis; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Itraconazole; Male; Mannans; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2014 |
9 other study(ies) available for galactose and itraconazole
| Article | Year |
|---|---|
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2000 |
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Galactose; Itraconazole; Lung Diseases, Fungal; Mannans; Neutropenia; Rabbits; Treatment Outcome; Triazoles | 2001 |
The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Cells, Cultured; Coculture Techniques; Culture Media; Fluconazole; Galactose; Humans; Itraconazole; Mannans; Monocytes | 2007 |
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles | 2012 |
Aspergillus nidulans galactofuranose biosynthesis affects antifungal drug sensitivity.
Topics: Antifungal Agents; Aspergillus nidulans; Biosynthetic Pathways; Caspofungin; Culture Media; Echinocandins; Fungal Proteins; Galactose; Gene Expression; Gene Expression Profiling; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction | 2012 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Crystallization; Dextrans; Drug Carriers; Emulsions; Ethylene Glycols; Excipients; Hexoses; Itraconazole; Male; Methylene Chloride; Rats; Rats, Sprague-Dawley; Solubility; Temperature | 2012 |
Statistically designed nonionic surfactant vesicles for dermal delivery of itraconazole: characterization and in vivo evaluation using a standardized Tinea pedis infection model.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Cholesterol; Colony Count, Microbial; Disease Models, Animal; Drug Design; Female; Hexoses; Itraconazole; Oxidative Stress; Rats, Wistar; Skin; Skin Absorption; Surface-Active Agents; Tinea Pedis | 2014 |
Anti-leishmanial effect of itraconazole niosome on in vitro susceptibility of Leishmania tropica.
Topics: Animals; Antiprotozoal Agents; Cholesterol; Drug Liberation; Hexoses; Itraconazole; Leishmania tropica; Liposomes; Macrophages, Peritoneal; Mice, Inbred BALB C | 2014 |